Exploring the Impact of Not Allowing Big Pharma to Advertise

This chapter delves into the frustrations with Pfizer and the implications of not allowing big pharma to advertise. It explores the influence of big pharma on mainstream media and Congress, as well as the connection between taxpayer funds in drug development and healthcare costs.